← Issue №4/ week of Jul 26, 2026/Colorectal

AI-Assisted Risk Stratification in Stage II Colorectal Cancer: Multi-Institutional Validation of Semantically-Enhanced Deep Learning.

From GI Signals issue №4: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

Colorectal retrospective · n=1,608 · Jul 28, 2026 · Gastroenterology · IF 25.1

AI-Assisted Risk Stratification in Stage II Colorectal Cancer: Multi-Institutional Validation of Semantically-Enhanced Deep Learning.

New evidenceartificial intelligencecolorectal cancerbiomarker
Clinical takeawayNo clinical action yet: validation of an AI tool for pathology slides. Consider future adoption if clinical trials confirm it improves adjuvant chemotherapy decisions in stage II CRC.
What it foundSÉMIL AI model stratified stage II CRC relapse risk (HR 1.98-4.73 across cohorts), outperforming non-semantic MIL (AUC 0.713-0.821 vs 0.686-0.803) and refining NCCN high-risk subgroup prognosis (HR 2.96-3.50).
ContextRefines but does not replace NCCN high-risk criteria (T4, MMR-D, etc.). First AI model to stratify within guideline-defined high-risk groups where treatment decisions are uncertain.
No standard claimed for this paper

Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.

Magisson F … Williams DS · Gastroenterology · IF 25.1 · PubMed ↗Permalink
← Read the whole of issue №4 Every paper GI Signals surfaces gets a page like this one. All issues